Eloxx Pharmaceuticals, Inc. (ELOX) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 134 transactions totaling $47.3M, demonstrating a bullish sentiment with $47.3M in net insider flow. The most recent transaction on Dec 1, 2021 involved a transaction of 219,326 shares valued at $0.
No significant insider buying has been recorded for ELOX in the recent period.
No significant insider selling has been recorded for ELOX in the recent period.
Based on recent SEC filings, insider sentiment for ELOX is bullish with an Insider Alignment Score of 100/100 and a net flow of $47.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Eloxx Pharmaceuticals, Inc. (ELOX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading ELOX stock, having executed 134 transactions in the past 90 days. The most active insider is Tomer Kariv (Executive), who has made 17 transactions totaling $13.3M.
Get notified when executives and directors at ELOX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Modur Vijay | Executive | Option Exercise | 219,326 | $N/A | $0 | |
| Dec 1, 2021 | Modur Vijay | Executive | Payment | 64,373 | $0.72 | $46.3K | |
| Dec 1, 2021 | Aggarwal Sumit | Executive | Payment | 81,933 | $0.72 | $59.0K | |
| Dec 1, 2021 | Aggarwal Sumit | Executive | Option Exercise | 279,158 | $N/A | $0 | |
| Dec 1, 2021 | Edmund Walts Alan | Executive | Option Exercise | 37,695 | $N/A | $0 | |
| Nov 29, 2021 | E. Geffken Daniel | Executive | Purchase | 50,000 | $0.72 | $36.0K | |
| Jul 30, 2021 | S. Belloff Neil | Executive | Option Exercise | 1,563 | $N/A | $0 | |
| Jul 30, 2021 | S. Belloff Neil | Executive | Payment | 459 | $1.32 | $606 | |
| May 25, 2021 | S. Belloff Neil | Executive | Option Exercise | 6,250 | $N/A | $0 | |
| May 25, 2021 | S. Belloff Neil | Executive | Payment | 1,835 | $1.39 | $2.6K | |
| May 13, 2021 | Kariv Tomer | Executive | Purchase | 592,592 | $1.35 | $800.0K | Large |
| May 13, 2021 | Kariv Tomer | Executive | Purchase | 1,422,222 | $1.35 | $1.9M | Large |
| May 13, 2021 | Kariv Tomer | Executive | Purchase | 2,630,487 | $1.35 | $3.6M | Large |
| May 13, 2021 | Kariv Tomer | Executive | Purchase | 1,280,624 | $1.35 | $1.7M | Large |
| May 13, 2021 | Nussbaum Ran | Executive | Purchase | 1,280,624 | $1.35 | $1.7M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 64 | $47.3M | 96.4% |
Payment(F) | 31 | $1.8M | 3.6% |
Exercise(M) | 33 | $0 | 0.0% |
Award(A) | 5 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at Eloxx Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 20 insiders making 134 transactions totaling $47.3M in purchases versus $0 in sales, the net buying activity of $47.3M signals strong executive confidence. Tomer Kariv (Executive) leads the buying activity with $13.3M in transactions across all time.